Clinical phase II study of double-unit cord blood transplantation for hematological malignancies.(C-SHOT 0507)
Phase 2
- Conditions
- Hematological malignancies
- Registration Number
- JPRN-C000000359
- Lead Sponsor
- A Research Grant on Human Genome, Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare: Research on advancement and safety security of HSCT using umbilical cord blood.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1) ECOG's performance status; 2 or more 2) Ejection fraction(EF); less than 50% 3) SaO2; more than 93% in room air 4) Serum creatinine; 1.3mg/dl or greater 5) Total bilirubin; 1.6mg/dl or greater, or GOT; 2 x normal value or greater 6) Down's syndrome 7) Fanconi's anemia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method